Clinical Trials Browser

Phase 1/2 × Leiomyosarcoma × toripalimab × Clear all

NCT06975293 2026-04-21

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Phase 1/2 Recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma